Economic analysis has much to contribute to our understanding of the impact of non-communicable diseases (NCDs) and how we prioritise interventions to address these conditions. The presentation will provide an overview of a broad-based health economics program at the George Institute for Global Health. First, the findings from ACTION will be presented. This study examines the economic burden of cancer in eight countries across South-East Asia, assessing outcomes such as catastrophic health expenditure and treatment discontinuation; and the role of health insurance coverage in protecting against such outcomes. Second, an overview of findings and methodologies used across a range of economic evaluations of novel interventions to address NCDs will be provided. Such evidence of cost-effectiveness gives guidance to decision makers on how to efficiently allocate health sector resources. Finally, the presentation will outline the current COACH project which is aimed at embedding economic evaluation into decision making through capacity development in Health Technology Assessment in China. The talk will end with a discussion around opportunities for wider collaboration.
Date: | 28 June 2022 (Tuesday) |
Time: | 1:00 – 2:00 pm (Hong Kong Time, GMT +8) |
Mode: | Zoom live webinar |
Speaker: | Professor Stephen Jan Co-Director of Health Systems, The George Institute for Global Health, University of New South Wales |
Moderator: | Professor Benjamin Yip Assistant Professor, JC School of Public Health and Primary Care |
About the speaker:
Prof Stephen Jan is Co-Director of Health Systems Science at the George Institute for Global Health, Conjoint Professor of Health Economics at the University of New South Wales and a Fellow of the Australian Academy of Health and Medical Sciences. His areas of expertise are economic evaluation, health financing, health sector priority setting, Indigenous and global health issues. He was a member of the Lancet Taskforce on NCDs and Economics. He has worked with governments, both in Australia and overseas, and with international agencies such as the WHO and industry. He has a strong interest in training and organisational capacity building in HTA and is currently involved in projects in China and India to investigate the translation of HTA evidence into government decision making.
About the moderator:
Prof Benjamin Yip is currently Assistant Professor at JC School of Public Health and Primary Care. In 2008, he received his Doctor of Philosophy (PhD) degree from Karolinska Institutet, Sweden. In parallel with his continued engagement on genetic epidemiological research, he is serving as the lead statistician in various clinical studies, ranging from clinical trials to cohort studies, steering committee member of Domestic Health Account (FHB), and a leading member of one WUN working group on integrated care model for multimorbidity. He is teaching health economics both on bachelor and post-graduate level.